10/31/2013 - 3:24pm

Insource Healthcare Solutions is adding wall-mounted and cart-mounted video systems at the hospitals it operates in upstate New York and Pennsylvania in order to allow for telehealth services and cut costs.

10/31/2013 - 3:17pm

Mylan experienced a slight dip in sales in its third quarter, due primarily to fluctuating currency values, the generic drug maker said Thursday.

10/31/2013 - 3:07pm

The "vast majority" of available mobile apps focused on health and wellness have limited functionality or evidence of value in advancing healthcare provision and outcomes, according to a new report by IMS Health.

10/31/2013 - 2:54pm

Impax Labs and Tolmar announced that the Food and Drug Administration has given final approval to Tolmar's generic version of Solaraze gel.

10/31/2013 - 2:38pm

Earlier this year, the Food and Drug Administration approved a new drug for treating cystic fibrosis for patients who have a specific genetic mutation, but that also treats the underlying cause of the disease rather than the disease itself.

10/31/2013 - 2:23pm

A personalized medicine company said a new study justifies clinical use of pharmacogenomic testing to help predict patients' response to psychiatric medications and improve treatment outcomes.

10/31/2013 - 1:11pm

The Food and Drug Administration is using long-term strategies to address drug shortages when they appear and requiring manufacturers to notify the agency if a shortage is at risk of happening, under a new plan announced Thursday.

10/31/2013 - 11:56am

Cardinal Health had sales of $24.5 billion and profits of $339 million in first quarter 2014, the company said.

10/31/2013 - 10:38am

Actavis is seeking Food and Drug Administration approval for a generic drug used to treat acne, triggering a lawsuit in a federal court from the maker of the branded version, the company said Thursday.